The authors examine outcomes of surgical and endovascular repair of popliteal artery injury and find that endovascular repair is increasingly being used.
The authors examine outcomes of surgical and endovascular repair of popliteal artery injury and find that endovascular repair is increasingly being used.
The authors conducted a study to determine the efficacy of sequential pneumatic compression therapy in patients with CLI between 2005 and 2015, where patients were commenced on a 12-week treatment protocol. Sustained clinical improvement was...
The authors conducted a study to determine the efficacy of sequential pneumatic compression therapy in patients with CLI between 2005 and 2015, where patients were commenced on a 12-week treatment protocol. Sustained clinical improvement was...
The authors conducted a study to determine the efficacy of sequential pneumatic compression therapy in patients with CLI between 2005 and 2015, where patients were commenced on a 12-week treatment protocol. Sustained clinical improvement was...
The authors conducted a study to determine the efficacy of sequential pneumatic compression therapy in patients with CLI between 2005 and 2015, where patients were commenced on a 12-week treatment protocol. Sustained clinical improvement was...
This retrospective analysis demonstrates that the implementation of a comprehensive limb salvage program can lead to increased angiographic assessment and endovascular treatment of high-risk CLI patients, preventing unnecessary major...
This retrospective analysis demonstrates that the implementation of a comprehensive limb salvage program can lead to increased angiographic assessment and endovascular treatment of high-risk CLI patients, preventing unnecessary major...
Stent fractures in the SFA play a modest role in the development of in-stent restenosis. In this study, a majority of patients with in-stent restenosis did not have stent fracture.
Stent fractures in the SFA play a modest role in the development of in-stent restenosis. In this study, a majority of patients with in-stent restenosis did not have stent fracture.
The Ocelot catheter allows for safe, quick, and efficient crossing of peripheral arterial CTOs while eliminating, or significantly reducing, fluoroscopic exposure and associated contrast administration.
The Ocelot catheter allows for safe, quick, and efficient crossing of peripheral arterial CTOs while eliminating, or significantly reducing, fluoroscopic exposure and associated contrast administration.
Pressure-wire gradient detection with and without provocative hyperemia testing using this novel approach may prove to be a useful adjunct in the diagnosis and treatment of lower-extremity occlusive disease.
Pressure-wire gradient detection with and without provocative hyperemia testing using this novel approach may prove to be a useful adjunct in the diagnosis and treatment of lower-extremity occlusive disease.
Knowledge of the regional distribution of wall thickness and failure properties in an AAA can help in understanding its natural history, developing methods to predict rupture risk, and designing vascular prostheses.
Knowledge of the regional distribution of wall thickness and failure properties in an AAA can help in understanding its natural history, developing methods to predict rupture risk, and designing vascular prostheses.
The authors conducted a retrospective analysis of hospital discharge data to determine national trends in carotid body tumors in the United States by year, incidence, patient demographics, and hospital covariates.
The authors conducted a retrospective analysis of hospital discharge data to determine national trends in carotid body tumors in the United States by year, incidence, patient demographics, and hospital covariates.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD)
Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD)
Cardiovascular...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System
LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System
LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness
Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness
Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...